Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 14 04:00PM ET
3.76
Dollar change
+0.69
Percentage change
22.48
%
IndexRUT P/E20.88 EPS (ttm)0.18 Insider Own8.13% Shs Outstand32.70M Perf Week-11.74%
Market Cap204.31M Forward P/E6.27 EPS next Y0.60 Insider Trans0.00% Shs Float30.04M Perf Month-19.31%
Income6.01M PEG0.17 EPS next Q0.08 Inst Own70.41% Short Float2.17% Perf Quarter-44.30%
Sales197.19M P/S1.04 EPS this Y404.44% Inst Trans-0.77% Short Ratio3.97 Perf Half Y-37.02%
Book/sh-4.19 P/B- EPS next Y32.16% ROA4.33% Short Interest0.65M Perf Year-29.06%
Cash/sh0.72 P/C5.19 EPS next 5Y121.27% ROE- 52W Range3.04 - 8.44 Perf YTD-39.16%
Dividend Est.- P/FCF5.16 EPS past 5Y-21.77% ROI- 52W High-55.45% Beta1.23
Dividend TTM- Quick Ratio1.03 Sales past 5Y12.53% Gross Margin69.42% 52W Low23.68% ATR (14)0.34
Dividend Ex-Date- Current Ratio1.32 EPS Y/Y TTM232.96% Oper. Margin16.62% RSI (14)38.99 Volatility11.93% 7.45%
Employees194 Debt/Eq- Sales Y/Y TTM6.38% Profit Margin3.05% Recom1.00 Target Price7.76
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-18.67% Payout0.00% Rel Volume4.86 Prev Close3.07
Sales Surprise-2.66% EPS Surprise-12.28% Sales Q/Q9.04% EarningsMar 12 AMC Avg Volume164.18K Price3.76
SMA20-12.28% SMA50-24.86% SMA200-37.29% Trades Volume797,870 Change22.48%
Date Action Analyst Rating Change Price Target Change
Dec-16-24Initiated Craig Hallum Buy
Feb-20-24Initiated B. Riley Securities Buy $9
Feb-01-24Initiated Jefferies Buy
Jun-24-22Initiated Cowen Outperform $11
Jun-23-22Initiated ROTH Capital Buy $9
Mar-13-25 07:03AM
03:09AM
Mar-12-25 05:15PM
04:05PM
Feb-26-25 04:05PM
04:10PM Loading…
Jan-30-25 04:10PM
Dec-18-24 09:40AM
Dec-16-24 03:34PM
Dec-04-24 09:55AM
Nov-29-24 09:40AM
Nov-22-24 09:55AM
Nov-18-24 08:00PM
09:55AM
Nov-13-24 09:40AM
09:00AM
06:15PM Loading…
Nov-12-24 06:15PM
04:05PM
Nov-11-24 07:19AM
Nov-01-24 09:55AM
Oct-29-24 04:05PM
Oct-28-24 09:40AM
Aug-08-24 09:57PM
04:05PM
Jul-25-24 04:05PM
Jul-09-24 09:55AM
Jun-24-24 03:27AM
Jun-20-24 04:45PM
May-20-24 10:08AM
May-09-24 11:14AM
May-08-24 06:48AM
09:56PM Loading…
May-07-24 09:56PM
06:50PM
05:54PM
04:05PM
Apr-30-24 10:00AM
Apr-29-24 04:05PM
Apr-23-24 04:05PM
Mar-13-24 08:37AM
Mar-12-24 06:11PM
04:05PM
Mar-05-24 10:00AM
Feb-27-24 04:05PM
Feb-20-24 04:05PM
Jan-25-24 04:05PM
Jan-17-24 04:05PM
04:05PM
Jan-11-24 04:05PM
Nov-07-23 08:25PM
04:45PM
Oct-24-23 08:30AM
Aug-10-23 06:40PM
04:30PM
Jul-27-23 08:30AM
Jul-13-23 09:29AM
Jun-22-23 07:00AM
Jun-08-23 06:05PM
Jun-05-23 07:48AM
May-31-23 08:30AM
May-30-23 08:30AM
May-09-23 05:21PM
05:21PM
Apr-26-23 08:30AM
Apr-10-23 08:30AM
Mar-31-23 09:55AM
Mar-28-23 04:15PM
Mar-27-23 09:00AM
Mar-02-23 08:00AM
Feb-09-23 04:15PM
Jan-09-23 05:30PM
Jan-05-23 06:00AM
Nov-10-22 08:30AM
Nov-08-22 04:15PM
Nov-07-22 09:15AM
Oct-31-22 08:30AM
Oct-10-22 07:45AM
Sep-07-22 08:30AM
08:30AM
Aug-25-22 04:05PM
Aug-24-22 08:30AM
Aug-15-22 04:56PM
Aug-09-22 04:15PM
Jul-20-22 11:00AM
Jul-18-22 10:24AM
Jun-16-22 08:30AM
Jun-06-22 04:05PM
08:16AM
Jun-03-22 08:59AM
May-26-22 04:05PM
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Peterson Robert CharlesChief Financial OfficerSep 09 '24Sale6.2032,874203,8480Sep 11 03:32 PM
Peterson Robert CharlesChief Financial OfficerJul 08 '24Option Exercise0.0044,250044,250Jul 10 04:31 PM
Peterson Robert CharlesChief Financial OfficerJul 09 '24Sale7.5711,37686,08432,874Jul 10 04:31 PM